Elanco Animal Health (ELAN) Invested Capital (2017 - 2026)

Elanco Animal Health has disclosed Invested Capital across 10 years of filings, most recently posting $10.2 billion for Q1 2026.

• Invested Capital for Q1 2026 came in at $10.2 billion, down 4.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.2 billion (down 4.76% YoY), and the FY2025 annual result was $10.3 billion, down 1.04% from the prior year.
• Invested Capital came in at $10.2 billion for Q1 2026 at Elanco Animal Health, down from $10.3 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $13.7 billion in Q1 2022 to a low of $10.2 billion in Q1 2026.
• The 5-year median for Invested Capital is $11.8 billion (2024), against an average of $11.7 billion.
• Across the five-year window, Invested Capital dropped 23.88% in 2024 and grew 4.54% in 2025, its largest moves.
• Elanco Animal Health's Invested Capital stood at $13.1 billion in 2022, then declined by 8.59% to $12.0 billion in 2023, then decreased by 13.17% to $10.4 billion in 2024, then dropped by 1.04% to $10.3 billion in 2025, then dropped by 0.71% to $10.2 billion in 2026.
• The last three Invested Capital figures came in at $10.2 billion (Q1 2026), $10.3 billion (Q4 2025), and $10.5 billion (Q3 2025), per Business Quant data.